{"id":57970,"date":"2024-07-18T00:33:20","date_gmt":"2024-07-17T22:33:20","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=57970"},"modified":"2024-07-17T15:02:37","modified_gmt":"2024-07-17T13:02:37","slug":"proc-biontech-ocekava-ze-prodej-vakcin-bude-na-podzim-na-urovni-pandemie","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2024\/07\/18\/proc-biontech-ocekava-ze-prodej-vakcin-bude-na-podzim-na-urovni-pandemie\/","title":{"rendered":"Pro\u010d BioNTech o\u010dek\u00e1v\u00e1, \u017ee prodej vakc\u00edn bude na podzim na \u00farovni pandemie?"},"content":{"rendered":"
<\/div>\n
\n
\n

N\u011bmeck\u00e1 spole\u010dnost BioNTech zab\u00fdvaj\u00edc\u00ed se mRNA, vlastn\u00edk a leg\u00e1ln\u00ed v\u00fdrobce produktu b\u011b\u017en\u011b zn\u00e1m\u00e9ho jako vakc\u00edna COVID-19 \u201ePfizer\u201c, je ve slo\u017eit\u00e9 pozici. Ne tak docela, proto\u017ee BioNTech dos\u00e1hl zisku z prodeje produktu v letech 2021 a 2022 t\u00e9m\u011b\u0159 30 miliard eur a st\u00e1le m\u00e1 18 miliard eur v hotovosti nebo pen\u011b\u017en\u00edch ekvivalentech.<\/span><\/p>\n

Ale proto\u017ee nebyl schv\u00e1len \u017e\u00e1dn\u00fd jin\u00fd produkt a trh s vakc\u00ednami COVID-19 p\u0159irozen\u011b zkolaboval, BioNTech sklouzl zp\u011bt do \u010derven\u00fdch \u010d\u00edsel. To je v\u0161e, co spole\u010dnost ud\u011blala od sv\u00e9ho zalo\u017een\u00ed v roce 2008 do roku 2021, a jak ned\u00e1vno uvedl Tagesspiegel, spole\u010dnost vyk\u00e1zala v prvn\u00edm \u010dtvrtlet\u00ed roku 2024 ztr\u00e1tu 300 milion\u016f EUR p\u0159i tr\u017eb\u00e1ch 187,6 milionu EUR.<\/span><\/p>\n

Spole\u010dnost je v\u0161ak zjevn\u011b p\u0159esv\u011bd\u010dena, \u017ee nast\u00e1vaj\u00ed dobr\u00e9 \u010dasy \u2013 alespo\u0148 pro ni \u2013, proto\u017ee o\u010dek\u00e1v\u00e1, \u017ee celkov\u00e9 tr\u017eby budou asi 15kr\u00e1t vy\u0161\u0161\u00ed, ne\u017e se odhaduje na rok 2024: mezi 2,5 a 3,1 miliardami eur. Finan\u010dn\u00ed \u0159editel BioNTech Jens Holstein: \u201eP\u0159edpokl\u00e1d\u00e1me, \u017ee v posledn\u00edch m\u011bs\u00edc\u00edch roku 2024 vygenerujeme p\u0159ibli\u017en\u011b 90 procent na\u0161ich celkov\u00fdch ro\u010dn\u00edch tr\u017eeb, p\u0159edev\u0161\u00edm ve \u010dtvrt\u00e9m \u010dtvrtlet\u00ed roku 2024.\u201c<\/span><\/p>\n

Dokonce i Tagesspiegel pova\u017euje tuto p\u0159edpov\u011b\u010f za p\u0159ekvapivou \u2013 nebo \u201eambici\u00f3zn\u00ed\u201c, jak p\u00ed\u0161\u00ed noviny. On uv\u00e1d\u00ed:<\/span><\/p>\n

V roce 2023 \u010dinily tr\u017eby [BioNTech] ve \u010dtvrt\u00e9m \u010dtvrtlet\u00ed m\u00e9n\u011b ne\u017e 40 % celkov\u00fdch tr\u017eeb a v roce 2022 to bylo je\u0161t\u011b m\u00e9n\u011b, necel\u00fdch 25 %. I cel\u00e1 druh\u00e1 polovina roku 2023 se na celkov\u00fdch tr\u017eb\u00e1ch pod\u00edlela pouze 62,2 %. V ka\u017ed\u00e9m z posledn\u00edch dvou let dos\u00e1hl BioNTech v prvn\u00edm \u010dtvrtlet\u00ed t\u0159etiny celkov\u00fdch tr\u017eeb.<\/span><\/em><\/p>\n

Vezm\u011bme progn\u00f3zu celkov\u00fdch tr\u017eeb BioNTech pro rok 2024 ve v\u00fd\u0161i 2,5 miliardy EUR na 3,1 miliardy EUR a vyd\u011blme rozd\u00edl za p\u0159edpokladu, \u017ee celkov\u00e9 tr\u017eby v tomto roce jsou 2,8 miliardy EUR. 90 % z 2,8 miliardy eur je 2,52 miliardy eur.<\/span><\/p>\n

To je 13n\u00e1sobek hodnoty za prvn\u00ed \u010dtvrtlet\u00ed. Vzhledem k nyn\u00ed obecn\u011b p\u0159ij\u00edman\u00e9 sez\u00f3nnosti infekc\u00ed Covid podobn\u00e9 ch\u0159ipce bude v\u0161ak prvn\u00ed \u010dtvrtlet\u00ed pravd\u011bpodobn\u011b stejn\u011b \u201edobr\u00e9\u201c \u010dtvrtlet\u00ed pro produkty Covid jako \u010dtvrt\u00e9 \u010dtvrtlet\u00ed \u2013 co\u017e potvrzuj\u00ed v\u00fd\u0161e uveden\u00e1 \u010d\u00edsla z Tagesspiegelu.<\/span><\/p>\n

Nav\u00edc progn\u00f3za 2,5 miliardy EUR na \u010dtvrt\u00e9 \u010dtvrtlet\u00ed nen\u00ed daleko od astronomick\u00fdch \u010dtvrtletn\u00edch \u010d\u00e1stek, kter\u00fdch BioNTech dos\u00e1hl b\u011bhem vrcholu Covidu. BioNTech dos\u00e1hl ve druh\u00e9m \u010dtvrtlet\u00ed roku 2022 obratu 3,2 miliardy EUR. Ve \u010dtvrt\u00e9m \u010dtvrtlet\u00ed roku 2022 to bude 4,3 miliardy eur.<\/span><\/p>\n

Pro\u010d spole\u010dnost o\u010dek\u00e1v\u00e1, \u017ee na podzim vyd\u011bl\u00e1 tolik pen\u011bz? V\u00ed BioNTech n\u011bco, co my ne?<\/span><\/p>\n<\/div>\n<\/div>\n

\n
\n

ZDROJ<\/a><\/span><\/h3>\n

 <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

N\u011bmeck\u00e1 spole\u010dnost BioNTech zab\u00fdvaj\u00edc\u00ed se mRNA, vlastn\u00edk a leg\u00e1ln\u00ed v\u00fdrobce produktu b\u011b\u017en\u011b zn\u00e1m\u00e9ho jako vakc\u00edna…<\/p>\n","protected":false},"author":2,"featured_media":57971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[4274,315,651],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/57970"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=57970"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/57970\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/57971"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=57970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=57970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=57970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}